Nanotechnology Approaches to Biology and Medicine
3rd February 2022
Timing : 2 pm EST
Please use this zoom link for joining the webinar
Note: Registration is Required. Register here
For a list of all talks at the NanoBio seminar Series Spring'22, see here
Biology functions at the nanoscale. Thus, there are special opportunities not only to make biological measurements using nanotechnology, but also to interact directly in order to influence biological outcomes. I describe how we fabricate and use nanostructures to advance high-throughput gene editing for cellular therapies targeting genetic diseases and cancer immunotherapy. We also use microfluidics and functionalized nanostructured features in the selective capture, probing, and release of single circulating tumor cells in liquid biopsies in order to diagnose cancers and to assess the efficacy of treatments. We exploit supramolecular assembly, acoustofluidics, specific surface functionalization, and plasmonics to enable these processes. Nanoscience and nanotechnology developed from chemistry, physics, biology, engineering, medicine, toxicology, and a host of other fields. Along the way, we taught each other our problems, challenges, and approaches. The interdisciplinary communication skills that were developed and are now part of our training remain unique to the field. As a result, nanoscience contributes to a wide range of other fields, such as neuroscience and the microbiome.
Paul S. Weiss
UC Presidential Chair
Distinguished Professor of Chemistry & Biochemistry, Bioengineering
Distinguished Professor of Materials Science & Engineering
University of California, Los Angeles, USA
Paul S. Weiss graduated from MIT with S.B. and S.M. degrees in chemistry in 1980 and from
the University of California at Berkeley with a Ph.D. in chemistry in 1986. He is a nanoscientist
and holds a UC Presidential Chair and is a distinguished professor of chemistry & biochemistry,
bioengineering, and materials science & engineering at UCLA, where he was previously director
of the California NanoSystems Institute. He also currently holds visiting appointments at
Harvard’s Wyss Institute and several universities in Australia, China, India, and South Korea. He
studies the ultimate limits of miniaturization, developing and applying new tools and methods for
atomic-resolution and spectroscopic imaging and patterning of chemical functionality. He and
his group apply these advances in other areas including neuroscience, microbiome studies, tissue
engineering, and high-throughput gene editing. He led, coauthored, and published the technology
roadmaps for the BRAIN Initiative and the U.S. Microbiome Initiative. He was the founding
editor-in-chief of ACS Nano and served in that role from 2017–2021. He has won a number of
awards in science, engineering, teaching, publishing, and communications. He is a fellow of the
American Academy of Arts and Sciences, American Association for the Advancement of
Science, American Chemical Society, American Institute for Medical and Biological
Engineering, American Physical Society, American Vacuum Society, Canadian Academy of
Engineering, IEEE, Materials Research Society, and an honorary fellow of the Chinese Chemical
Society and Chemical Research Society of India.